Login or Sign Up
14:00 Feb 25
Concord Drugs Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Concord Drugs Ltd. Corporate Actions
Concord Drugs Ltd.
Industry Pharmaceuticals
14:00 Feb 25
Quality
50/100
Medium Financial Strength
Valuation
48/100
Mid Valuation
Technical
59/100
Technically Neutral
Strength
3
Weakness
8
Opportunity
0
Threats
0
0.00 %
Dividend Yield
366.20
Market Cap (Cr)
RSI
54.39 %
Promoter Holding
0.74 %
Net Profit Margin
| Ex-Date | Type | Description | Record Date | Ratio | Dividend Type |
|---|
Download Our App On:
Back
OTP sent to your mobile number. Please enter it below to verify.
Verify Email OTP
OTP sent to
Dear User, please
complete your profile!
Email ID Already Exists
Location Saved
Successfully
Email Id Verified
Successfully